Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Mulshine

Showing results (81-90 of 123) with videos related to

Pageof 13
Sort By:
Cancer Research|May 1, 1992
The correct dose: pharmacologically guided end point for anti-growth factor therapyJ L Mulshine, N Shuke, F Daghighian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1997
High frequency of K-ras codon 12 mutations in bronchoalveolar lavage fluid of patients at high risk for second primary lung cancerF M Scott, R Modali, T A Lehman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 1998
Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokersJ Zhou, J L Mulshine, J Y Ro, et al.
Cancer Research|September 15, 1991
ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intentT Mitsudomi, S M Steinberg, H K Oie, et al.
Cancer Research|April 1, 1991
[Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivoS Mahmoud, J Staley, J Taylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Topical delivery of 13-cis-retinoic acid by inhalation up-regulates expression of rodent lung but not liver retinoic acid receptorsD L Wang, M Marko, A R Dahl, et al.
Cancer|August 1, 1993
Scientific basis for cancer prevention. Intermediate cancer markersJ L Mulshine, M Jett, F Cuttitta, et al.
Cancer Research|July 15, 1988
Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine originA F Gazdar, L J Helman, M A Israel, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
In vivo diagnosis and therapy of human tumors with monoclonal antibodies: selection of antibodies and preliminary clinical studies in small cell carcinoma of the lungJ L Mulshine, I Avis, A M Treston, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Association between histological type and neuroendocrine differentiation on drug sensitivity of lung cancer cell linesA F Gazdar, C Kadoyama, D Venzon, et al.
Pageof 13

Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
Cancer Research|May 1, 1992
The correct dose: pharmacologically guided end point for anti-growth factor therapyJ L Mulshine, N Shuke, F Daghighian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1997
High frequency of K-ras codon 12 mutations in bronchoalveolar lavage fluid of patients at high risk for second primary lung cancerF M Scott, R Modali, T A Lehman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 1998
Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokersJ Zhou, J L Mulshine, J Y Ro, et al.
Cancer Research|September 15, 1991
ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intentT Mitsudomi, S M Steinberg, H K Oie, et al.
Cancer Research|April 1, 1991
[Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivoS Mahmoud, J Staley, J Taylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Topical delivery of 13-cis-retinoic acid by inhalation up-regulates expression of rodent lung but not liver retinoic acid receptorsD L Wang, M Marko, A R Dahl, et al.
Cancer|August 1, 1993
Scientific basis for cancer prevention. Intermediate cancer markersJ L Mulshine, M Jett, F Cuttitta, et al.
Cancer Research|July 15, 1988
Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine originA F Gazdar, L J Helman, M A Israel, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
In vivo diagnosis and therapy of human tumors with monoclonal antibodies: selection of antibodies and preliminary clinical studies in small cell carcinoma of the lungJ L Mulshine, I Avis, A M Treston, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Association between histological type and neuroendocrine differentiation on drug sensitivity of lung cancer cell linesA F Gazdar, C Kadoyama, D Venzon, et al.
Pageof 13